Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
Where this comes from
- Record sourced from PubMed, PMID 30395525.
- Also identified by DOI 10.3949/ccjm.85a.17119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atypical femoral fracture is a rare but serious complication of long-term bisphosphonate therapy. Although the benefit of preventing osteoporotic fractures greatly outweighs the risk of atypical fracture in bisphosphonate users, concern about atypical fracture risk has led to a decrease in bisphosphonate use. What are the risks, and how do we treat atypical femoral fracture?
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Femoral Fractures
- Osteoporosis
- Osteoporotic Fractures